OTC · Drug Manufacturers - Specialty & Generic

Benchmark Holdings plc (BHCCF) Stock

$0.37 +0.00% OTC: BHCCF Healthcare

Benchmark Holdings plc is dedicated to empowering the food and agriculture sectors by furnishing specialized knowledge, services, and products. The company's operations are divided into three core divisions: Genetics, Advanced Nutrition, and Health.

Valuation

MetricValue
Price$0.37
Market Cap$225.11M
P/E Ratio-4.13
P/B Ratio0.75
P/S Ratio1.50
EPS (TTM)$-0.05
52-Week High$0.40
52-Week Low$0.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-15.96%
ROA-10.25%
ROCE-14.88%
Gross Margin48.63%
Operating Margin-39.28%
Net Margin-43.67%
Debt/Equity0.33
Current Ratio1.73

Annual Financials (USD)

Metric20202021202220232024
Revenue$106.0M$125.0M$158.0M$169.0M$90.0M
Operating Profit$-11.0M$-5.0M$-6.0M$-5.0M$-35.0M
Net Profit$-33.0M$-13.0M$-32.0M$-23.0M$-39.0M
EPS$-0.05$-0.02$-0.05$-0.02$-0.05
Op Margin-10.3%-4.3%-3.9%-3.1%-39.3%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$489.0M$482.0M$527.0M$471.0M$385.0M
Total Liabilities$194.0M$202.0M$203.0M$189.0M$161.0M
Cash$72.0M$39.0M$36.0M$37.0M$23.0M
Borrowings$109.0M$120.0M$110.0M$102.0M$72.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-4.0M$6.0M$11.0M$20.0M$2.0M
Investing Cash Flow$19.0M$-46.0M$-24.0M$-12.0M$-7.0M
Financing Cash Flow$-11.0M$-12.0M$-10.0M$-19.0M$-17.0M
Net Cash Flow$56.0M$-32.0M$-3.0M$0$-13.0M
Free Cash Flow$-15.0M$-17.0M$-2.0M$13.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.04
EV / EBITDA46.63
FCF Yield-1.42%
Quick Ratio1.57
Interest Coverage-3.94
Return 1Y0.00%
Return 3Y-53.70%
Return 5Y—

Ownership

Insiders Held9.14%
Institutions Held102.75%
Institutions Float Held113.10%
Institutional HolderSharesReport Date
John Hancock Funds II-International Small Company Fund7792025-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABTIAlterola Biotech, Inc. $0.00 — -0.11 $291900 0.00%
BHHKFCraftport Cannabis Corp. $0.00 — 0.00 $884 0.00%
CPHRFCipher Pharmaceuticals Inc. $11.68 -0.17% 9.56 $296.57M 0.00%
EVGRFChina Evergrande New Energy Vehicle Group Limited $0.00 — -0.13 $2.17M 0.00%
MAYNFMayne Pharma Group Limited $1.97 +0.00% -2.55 $160.30M 0.00%

About Benchmark Holdings plc

Benchmark Holdings plc is dedicated to empowering the food and agriculture sectors by furnishing specialized knowledge, services, and products. The company's operations are divided into three core divisions: Genetics, Advanced Nutrition, and Health. Within its Genetics arm, Benchmark provides cutting-edge breeding technologies and facilities for species such as sea bass/bream, salmon, shrimp, and tilapia, delivering genetically superior ova. The Advanced Nutrition division focuses on creating and supplying vital nutritional and health products specifically for the aquaculture industry. Meanwhile, the Health segment offers crucial medicinal solutions for the aquaculture market, including treatments like Ectosan Vet and CleanTreat for sea lice. Founded in 2000 and headquartered in Sheffield, United Kingdom, Benchmark Holdings plc maintains a broad international presence, conducting business in diverse regions including the UK, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, other European countries, and worldwide.

Benchmark Holdings plc is headquartered in GB.

Benchmark Holdings plc (BHCCF) stock trades at $0.37 with a market capitalization of $225.11M. The stock is valued at a price-to-earnings (P/E) ratio of -4.13, price-to-book of 0.75, price-to-sales of 1.50. Over the past 52 weeks the stock has ranged between $0.37 and $0.40, and currently trades 7.5% below its 52-week high.

On profitability, Benchmark Holdings plc generates a return on equity (ROE) of -15.96%, return on capital employed of -14.88%, an operating margin of -39.28%, a net profit margin of -43.67%.

Official website: www.benchmarkplc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides